Form 4 for MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.
Accepted 2025-06-18 00:00:00 ET · period of report 2025-06-16 · accession 0001823239-25-000086 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-18 | 2025-06-16 | MRVI | LUCIER GREGORY T | Dir | A - Grant | $2.16 | +89.1K | 144.3K | +162% | +$192.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-06-16 | A | A | 89,139 | $2.16 | 144,262 | D | — | — | (F1) Represents restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan on June 16, 2025, which vest in full upon the earlier of one year from the date of grant or the date of the 2026 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders. |